Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab-Reference-Cited by-同舟云学术

Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Published:2016-08-22 Issue:9-10 Volume:55 Page:1175-1182
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Skougaard Kristin¹,Nielsen Dorte¹,Jensen Benny Vittrup¹,Pfeiffer Per²,Hendel Helle Westergren³

Affiliation:

1. Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark;

2. Department of Oncology, Odense University Hospital, Odense, Denmark;

3. Department of Nuclear Medicine, Copenhagen University Hospital Herlev, Herlev, Denmark

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2016.1170197

Reference25 articles.

1. 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY AS A TOOL FOR RESPONSE PREDICTION IN SOLID TUMOURS

2. Molecular imaging in cancer treatment

3. The Lessons of GIST—PET and PET/CT: A New Paradigm for Imaging

4. Monitoring chemotherapy and radiotherapy of solid tumors

5. Positron Emission Tomography As an Imaging Biomarker

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy;Egyptian Journal of Radiology and Nuclear Medicine;2021-11-29

2. The area between ROC curves, a non‐parametric method to evaluate a biomarker for patient treatment selection;Biometrical Journal;2020-04-28

3. A systematic review of salvage therapies in refractory metastatic colorectal cancer;International Journal of Colorectal Disease;2020-03-26

4. Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial;British Journal of Cancer;2018-07

5. Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges;Minerva Surgery;2017-07